221 related articles for article (PubMed ID: 16252508)
1. [Prescription by INN (International Non-Proprietary Name)].
Elsen C; Nève J; Schetgen M
J Pharm Belg; 2005; 60(3):77-83. PubMed ID: 16252508
[No Abstract] [Full Text] [Related]
2. [Generic name or brand name?].
Madsen S
Tidsskr Nor Laegeforen; 2006 Feb; 126(4):431. PubMed ID: 16477277
[No Abstract] [Full Text] [Related]
3. Prescribing generic drugs using a generic name: Are we teaching it right?
Kamath A
Indian J Med Ethics; 2016; 1(3):194. PubMed ID: 27474700
[TBL] [Abstract][Full Text] [Related]
4. [The information potential of the names of drugs].
Springer V; Kolár J; Chalabala M
Vnitr Lek; 2004 Feb; 50(2):91-7. PubMed ID: 15077580
[TBL] [Abstract][Full Text] [Related]
5. By any other name: ambiguity in marketing proprietary anti-infective agents.
Berger SA
Clin Infect Dis; 2007 Jan; 44(1):65-8. PubMed ID: 17143817
[TBL] [Abstract][Full Text] [Related]
6. Think INN, prescribe INN, dispense INN: good professional practice.
Prescrire Int; 2000 Dec; 9(50):184-90. PubMed ID: 11475502
[TBL] [Abstract][Full Text] [Related]
7. [Generic prescription should be evaluated as new way of prescription in Denmark].
Hellebek A; Søndergaaard J; Thirstrup S; Sales Y
Ugeskr Laeger; 2012 Aug; 174(35):1974. PubMed ID: 22929572
[No Abstract] [Full Text] [Related]
8. [Generic drugs instead of brand drugs prescriptions--long overdue].
Nelson S; Slørdal L; Spigset O
Tidsskr Nor Laegeforen; 2006 Feb; 126(4):441-3. PubMed ID: 16477280
[TBL] [Abstract][Full Text] [Related]
9. [Generic drugs and legal incentives: which impact?].
Livio F; Buclin T; Pannatier A; Biollaz J
Rev Med Suisse; 2006 Apr; 2(61):966-9. PubMed ID: 16686328
[TBL] [Abstract][Full Text] [Related]
10. [Prescription in International Common Denomination. A new challenge for general physicians?].
Schetgen M
Rev Med Brux; 2005; 26(3):S181-3. PubMed ID: 16038145
[No Abstract] [Full Text] [Related]
11. [Prescribing drugs by international non-proprietary name: the perception of health and non-health professionals].
Biga J; Taboulet F; Lapeyre-Mestre M; Duguet AM; Vincent S; Montastruc JL
Therapie; 2005; 60(4):401-7. PubMed ID: 16268440
[TBL] [Abstract][Full Text] [Related]
12. International Nonproprietary Names (INN) for pharmaceutical substances.
Kopp-Kubel S
Bull World Health Organ; 1995; 73(3):275-9. PubMed ID: 7614659
[TBL] [Abstract][Full Text] [Related]
13. [Generic medications and prescription by non-proprietary name].
Delporte JP; Delattre L; Herné P
Rev Med Liege; 2006; 61(5-6):459-63. PubMed ID: 16910276
[TBL] [Abstract][Full Text] [Related]
14. [Nomenclature of drugs and the prescription structure (concerning the article of Docent M.N. Cherniavskiĭ "Professional language of the physician and prescriptions")].
Pershin GN
Sov Med; 1976 Apr; (4):55-6. PubMed ID: 982144
[No Abstract] [Full Text] [Related]
15. Generically speaking.
Drug Ther Bull; 2009 Oct; 47(10):109. PubMed ID: 19809083
[TBL] [Abstract][Full Text] [Related]
16. Physician use of brand versus generic drug names in 1993-1994 and 2003-2004.
Kwo EC; Kamat P; Steinman MA
Ann Pharmacother; 2009 Mar; 43(3):459-68. PubMed ID: 19261956
[TBL] [Abstract][Full Text] [Related]
17. Operational rules for the implementation of INN prescribing.
Van Bever E; Wirtz VJ; Azermai M; De Loof G; Christiaens T; Nicolas L; Van Bortel L; Vander Stichele R
Int J Med Inform; 2014 Jan; 83(1):47-56. PubMed ID: 24168761
[TBL] [Abstract][Full Text] [Related]
18. Are drug proprietary names necessary?
D'Arcy PF; Hadden DR
Adverse Drug React Toxicol Rev; 2000 Jun; 19(2):117-21. PubMed ID: 10967746
[No Abstract] [Full Text] [Related]
19. [Common international names and trademarks in the pharmaceutical field].
Pasotti V
Boll Chim Farm; 1989 Apr; 128(4):121-4. PubMed ID: 2775524
[TBL] [Abstract][Full Text] [Related]
20. Obstacles to the universal application of INNs.
Prescrire Int; 2014 Oct; 23(153):248-51. PubMed ID: 25964979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
